Your browser doesn't support javascript.
loading
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.
Tanuma, Sei-Ichi; Katsuragi, Kiyotaka; Oyama, Takahiro; Yoshimori, Atsushi; Shibasaki, Yuri; Asawa, Yasunobu; Yamazaki, Hiroaki; Makino, Kosho; Okazawa, Miwa; Ogino, Yoko; Sakamoto, Yoshimi; Nomura, Miyuki; Sato, Akira; Abe, Hideaki; Nakamura, Hiroyuki; Takahashi, Hideyo; Tanuma, Nobuhiro; Uchiumi, Fumiaki.
Afiliação
  • Tanuma SI; Department of Genomic Medicinal Science, Research Institute for Science and Technology, Organization for Research Advancement, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Katsuragi K; Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Oyama T; Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Yoshimori A; Hinoki Shinyaku Co., Ltd., Chiyoda-ku, Tokyo 102-0084, Japan.
  • Shibasaki Y; Institute for Theoretical Medicine Inc., Fujisawa, Kanagawa 251-0012, Japan.
  • Asawa Y; Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Yamazaki H; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Makino K; Hinoki Shinyaku Co., Ltd., Chiyoda-ku, Tokyo 102-0084, Japan.
  • Okazawa M; Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Ogino Y; Department of Genomic Medicinal Science, Research Institute for Science and Technology, Organization for Research Advancement, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Sakamoto Y; Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Nomura M; Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Sato A; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
  • Abe H; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
  • Nakamura H; Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
  • Takahashi H; Hinoki Shinyaku Co., Ltd., Chiyoda-ku, Tokyo 102-0084, Japan.
  • Tanuma N; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Uchiumi F; Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
Molecules ; 25(16)2020 Aug 10.
Article em En | MEDLINE | ID: mdl-32785052
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Inibidores Enzimáticos / Nicotinamida Fosforribosiltransferase Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Inibidores Enzimáticos / Nicotinamida Fosforribosiltransferase Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão